BA vs DHR: Which Is the Better Buy?
Side-by-side comparison of The Boeing Company and Danaher Corporation — fair value, conviction, valuation metrics, and QuantHub research signals.
Updated 2026-05-04.
The Boeing Company · Industrials
$231.28
+82.7% upside to fair value
Grade C
VS
Danaher Corporation · Healthcare
$174.04
+13.2% upside to fair value
Grade B
QuantHub Verdict
BA has more upside to fair value
(+82.7%).
DHR trades at a lower forward P/E
(33.4x).
These are model outputs — not personalized investment advice.
See all research →
Valuation & Fundamentals
| Metric |
BA |
DHR |
| Current Price |
$231.28 |
$174.04 |
| Fair Value Estimate |
$422.56 |
$197.01 |
| Upside to Fair Value |
+82.7%
|
+13.2%
|
| Market Cap |
$181.8B |
$123.2B |
| Forward P/E |
83.4x
|
33.4x
|
| EV / EBITDA |
30.8x
|
20.3x
|
| Price / Sales |
2.0x
|
5.0x
|
| Price / FCF |
776.7x
|
23.3x
|
| Revenue Growth YoY |
+14.0%
|
+3.7%
|
| Gross Margin |
4.8%
|
60.7%
|
| Operating Margin |
-5.9%
|
21.0%
|
| Return on Equity |
-8723.1%
|
7.1%
|
| Dividend Yield |
0% |
0% |
| FCF Yield |
0.13%
|
4.3%
|
| Analyst Consensus |
Strong Buy
|
Strong Buy
|
Investment Thesis
The Boeing Company is a leading global aerospace and defense firm operating across commercial airplanes, defense, space and security, and global services segments. Despite a challenging operating margin of negative 5.9% and a high trailing P/E of 83.43, Boeing is currently fairly valued with a fair value estimate of $422.56, implying an 82.7% upside from the current price of $231.28. The company …
Danaher Corporation is a diversified healthcare company focused on medical diagnostics, life sciences, and biotechnology, generating approximately $24 billion in revenue with a strong recurring revenue base of over 81%. The company benefits from a high gross margin of 60.7% and solid operating margin of 21%, supported by a seasoned management team with a proven capital allocation track record inc…
Accumulation Zones
| Metric |
BA |
DHR |
| Zone Low |
$316.92 |
$147.76 |
| Zone High |
$359.18 |
$167.46 |
| In Buy Zone? |
Yes
|
No
|